"The Report
Mauritius Pharmaceuticals Report provides information on pricing,
market analysis, shares, forecast, and company profiles for key
industry participants. - MarketResearchReports.biz"
The Mauritius
Pharmaceuticals Report
features Business Monitor International (BMI)'s forecasts for drugs
and healthcare expenditure and imports and exports, focusing on the
growth outlook for the prescription, OTC, patented drugs and generics
market segments.
BMI's Mauritius Pharmaceuticals
Report provides industry professionals, strategists, company
executives, investors, analysts and sales/marketing heads with
independent forecasts and competitive intelligence on the Mauritius
pharmaceutical and healthcare industry.
Key Benefits
- Benchmark BMI's pharmaceutical and healthcare market forecasts for Mauritius, to test other views a key input for successful budgeting and strategic business planning in the Mauritian pharmaceutical and healthcare market.
- Target business opportunities and risks in the Mauritian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Mauritius.
- Assess the activities, strategy and market position of your competitors via our Company Profiles (inc. SWOTs, KPIs and latest activity) and Competitive Landscape Tables.
Download Sample copy of this
Report at:
Coverage
BMI Industry View
An at-a-glance perspective on
the latest regulatory developments, key forecast indicators and major
corporate developments, covering the prescription, OTC and generics
markets. The pharmaceuticals and healthcare SWOT outlines strategic
factors that affect the basic assumptions underpinning BMI’s
forecast analysis, and taken together with BMI’s political,
economic and business environment SWOTs, it gives a complete overview
of market climate.
BMI Industry Forecast
Scenario
Industry forecasts to
end-2019 for all key indicators, supported by explicit assumptions,
plus analysis of key downside risks to the main forecasts:
- Healthcare: Total healthcare expenditure (USDbn), healthcare expenditure (% of GDP), healthcare expenditure per capita (USD), hospital beds, doctors, and birth & mortality rates (all per ‘000 population).
- Pharmaceutical Market: Drug expenditure in USDbn, % of GDP and per capita (USD).
- Patented Drug Market: Prescription drug sales (USDbn & % of total sales).
- Generic Drug Market: Generic product sales (USDbn), generic sales (% of total sales).
- OTC Drug Market: OTC sales (USDbn & % of total sales).
Macroeconomic Forecasts:
Nominal and real GDP, % real GDP growth, % private consumption
growth, % industrial output growth, % consumer price index, % GDP
price deflator, exports, imports, trade balance, current account
balance, foreign direct investment, exchange rate against USD,
government expenditure and external debt.
BMI’s Pharmaceuticals and
Healthcare Risk Reward Index
BMI’s Risk Reward Index
provides investors (both national and multinational) looking for
opportunities in the region with a clear country-comparative
assessment of the market’s risks and potential rewards. Each of the
country markets are scored using a sophisticated model that includes
more than 40 industry, economic and demographic data points to
provide indices of highest to lowest appeal to investors, with each
position explained.
Market Summary
A snapshot of key market
characteristics, including total size of the pharmaceuticals and
healthcare segments, growth drivers, leading therapeutic areas and
the competitive landscape
Industry Developments
A focus on government
healthcare reforms, epidemiological trends, mergers and acquisitions,
product launches, market entries, FDI activity, R&D,
biotechnology, clinical trials and supply chain issues.
Regulatory Regime
Details of the industry
regulatory framework and key legislation covering the licensing of
new products/services, pricing and reimbursements, intellectual
property, taxation and advertising, as well as analysis of the
overall regulatory burden.
Competitive Landscape
The competitive landscape
section provides comparative company analyses and index by USD sales
and % share of total sales – for the total pharmaceutical sector,
as well as the OTC, generics and distribution sub-sectors.
Company Profiles*
Examines the competitive
positioning and short- to medium-term business strategies of key
industry players. Strategy is examined within the context of BMI’s
industry forecasts, our macroeconomic views and our understanding of
the wider competitive landscape to generate Company SWOT analyses.
The latest financial and operating statistics and key company
developments are also incorporated within the company profiles,
enabling a full evaluation of recent company performance and future
growth prospects.
Browse Our Press Releases by
Prnewswire:
Table of Contents
BMI Industry View7
SWOT8
Political9
Economic10
Industry Forecast11
Pharmaceutical Market
Forecast11
Table: Pharmaceutical Sales,
Historical Data And Forecasts (Mauritius 2010-2018)12
Healthcare Market Forecast14
Table: Healthcare Expenditure
Trends, Historical Data And Forecasts (Mauritius 2010-2018)15
Macroeconomic Forecasts17
Economic Analysis17
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
USA:
Canada Toll Free: 866-997-4948
Tel:
+1-518-621-2074
No comments:
Post a Comment